menu
Systemic Aspergillosis Systemic Candidiasis Treatment Market Growth Set to Surge Significantly during 2031
Systemic Aspergillosis Systemic Candidiasis Treatment Market Growth Set to Surge Significantly during 2031
Aspergillosis is an infection triggered by a type of mold (fungus). The illnesses caused by aspergillosis infection usually affect the respiratory system. Most strains of this mold are mild; however, a few can cause severe illnesses with weakened immune systems, underlying lung disease or asthma due to inhalation of fungal spores.

·         Aspergillosis is an infection triggered by a type of mold (fungus). The illnesses caused by aspergillosis infection usually affect the respiratory system. Most strains of this mold are mild; however, a few can cause severe illnesses with weakened immune systems, underlying lung disease or asthma due to inhalation of fungal spores.

·         Systemic candidiasis is a common fungal infection among hospitalized people in high-income countries. Systematic candidiasis treatment generally comprises oral or intravenous (IV) antifungal medications.

Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=83886

Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market: Key Trends

·         The global systemic aspergillosis and systemic candidiasis treatment market is driven by increase in incidence of fungal diseases and rise in prevalence of hospital-acquired fungal infection. Candidemia is one of the most common bloodstream infections in the U.S. During 2013–2017, the average incidence of candidemia was nine per 100,000 people in the country.

·         Rise in research & development activities and new drug pipeline are projected to drive the global market during the forecast period. However, undiagnosed cases of systemic aspergillosis and systemic candidiasis are anticipated to restrain the global market.

Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Segmentation

·         In terms of type, the global systemic aspergillosis and systemic candidiasis treatment market can be classified into voriconazole, liposomal amphotericin B, systemic oral azoles, topical antifungal agents, and others. The systemic oral azoles segment accounted for major share of the global market in 2020.

·         Based on application, the global systemic aspergillosis and systemic candidiasis treatment market can be divided into chronic pulmonary aspergillosis (CPA), allergic bronchopulmonary aspergillosis (ABPA), gastrointestinal candidiasis, genitourinary tract candidiasis, and others. The allergic bronchopulmonary aspergillosis (ABPA) segment held significant share of the global market in 2020.

Request COVID Analysis on Systemic Aspergillosis Systemic Candidiasis Treatment Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=83886

North America accounted for Major Share of Global Market

·         North America is projected to dominate the global market during the forecast period due to increase in awareness about fungal and infectious diseases. Additionally, rise in prevalence of immunological diseases and increase in health care expenditure are anticipated to drive the systemic aspergillosis and systemic candidiasis treatment market in North America during the forecast period.

·         The market in Asia Pacific is expected to grow at a rapid pace during the forecast period due to rise in prevalence of fungal diseases and increase in hospital-acquired fungal infections

Pre Book Systemic Aspergillosis Systemic Candidiasis Treatment Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=83886&ltype=S

Key Players Operating in Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market

Major players operating in the global systemic aspergillosis and systemic candidiasis treatment market are:

·         Basilea Pharmaceutica Ltd.

·         Astellas Pharma, Inc.

·         Grupo Ferrer International, S.A.

·         Pacgen Life Science Corporation

·         NovaDigm Therapeutics, Inc.

·         Cidara Therapeutics, Inc.

·         Amplyx Pharmaceuticals, Inc.

·         Pfizer, Inc.

·         Novartis AG

·         Sanofi

·         Merck & Co., Inc.

·         Bayer AG

·         GlaxoSmithKline plc.

·         Abbott

·         Cipla, Inc.

·         Ferrer International

·         Other prominent players

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

 

Website: https://www.transparencymarketresearch.com/